US Broker Ratings

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Major Upside Potential with a 110% Increase on the Horizon

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is making waves in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. Headquartered in Durham, North Carolina, this biotechnology company..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating a 17.10% Potential Upside in the Biotech Sector

PTC Therapeutics, Inc. (NASDAQ: PTCT) is a biopharmaceutical company with a focus on rare disorders, showcasing a compelling investment opportunity in the healthcare sector. With a market capitalization of $4.52..

Certara, Inc. (CERT) Stock Analysis: Unpacking a 31.88% Potential Upside in Healthcare Innovation

Certara, Inc. (NASDAQ: CERT) is an intriguing player in the healthcare sector, particularly within the health information services industry. With a market capitalization of $1.72 billion, Certara offers a unique..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A 7.94% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a key player in the healthcare sector, specifically in the medical instruments and supplies industry, offers a compelling investment case for individual investors. Headquartered in..

Premier, Inc. (PINC) Stock Analysis: Navigating a Challenging Landscape with Strategic Resilience

Premier, Inc. (NASDAQ: PINC) stands as a notable player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $2.24 billion, this Charlotte, North..

Harmony Biosciences Holdings, Inc. (HRMY) Stock Analysis: Unpacking a Promising 41% Potential Upside in Biotechnology

Investors seeking opportunities in the healthcare sector, particularly within biotechnology, should turn their attention to Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY). With a market capitalization of $2.06 billion, this commercial-stage..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: Exploring a 27% Potential Upside with Strong Buy Ratings

For investors seeking promising opportunities in the healthcare sector, Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) may warrant a closer look. This London-based biopharmaceutical company is making waves with its innovative therapies..

Warby Parker Inc. (WRBY) Stock Analysis: Navigating a 52.81 Forward P/E in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Warby Parker Inc. (NYSE: WRBY) presents an intriguing case. With a market capitalization of $3.26 billion, the eyewear company has carved out..

UFP Technologies, Inc. (UFPT) Stock Analysis: A 60% Upside Potential in the Healthcare Sector

UFP Technologies, Inc. (NASDAQ: UFPT) is attracting considerable attention from investors, particularly in the healthcare sector, where it has carved a niche as a key player in the medical devices..

NewAmsterdam Pharma (NAMS) Stock Analysis: Potential 63% Upside in Pioneering Biotech

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a pioneering force in the biotechnology sector, is capturing investor interest with its promising pipeline and significant potential upside. Headquartered in Naarden, the Netherlands,..

Scholar Rock Holding Corporation (SRRK): Investor Outlook on a Biotech Powerhouse with 58% Upside

Scholar Rock Holding Corporation (NASDAQ: SRRK) stands out as a compelling investment opportunity in the biotechnology sector, particularly for investors with a keen interest in companies poised for substantial growth..

CG Oncology (CGON) Stock Analysis: 75% Upside Potential in Biotech Sector

CG Oncology, Inc. (NASDAQ: CGON) is generating a buzz in the biotechnology sector with its impressive potential upside, making it a compelling consideration for investors seeking growth in the healthcare..

Ascentage Pharma Group (AAPG): Navigating the Biotech Terrain with an Eye on Innovation

Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology company based in Suzhou, China, is carving out a niche in the healthcare sector with its focus on developing therapies for cancers,..

Acadia Healthcare Company, Inc. (ACHC) Investor Outlook: Analyzing a 35% Upside Potential with Strategic Growth

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a significant player in the behavioral healthcare sector, serving the United States and Puerto Rico with a diverse range of services. With a..

Perrigo Company plc (PRGO) Investor Outlook: Evaluating a Compelling 53% Upside Potential

Perrigo Company plc (NYSE: PRGO), a Dublin-based leader in the healthcare sector, has grabbed investor attention with its promising 53.38% upside potential. Specializing in over-the-counter health and wellness solutions, the..

Concentra Group Holdings Parent (CON): Investor Outlook with a Promising 23.68% Upside Potential

Concentra Group Holdings Parent, Inc. (NYSE: CON), a prominent player in the healthcare sector, offers investors an intriguing opportunity with its strong market positioning and strategic offerings in occupational health..

HUTCHMED (China) Limited (HCM) Stock Analysis: Exploring a 41.69% Potential Upside in the Healthcare Sector

HUTCHMED (China) Limited (NASDAQ: HCM) is a prominent player in the healthcare sector, specifically within the drug manufacturing industry. Headquartered in Hong Kong, the company is making significant strides in..

Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Analysis: A Potential 69.87% Upside Beckons Investors

Investors with a keen eye on the biotechnology sector may find Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) a compelling opportunity, especially with the stock’s potential upside of nearly 69.87% based on..

Catalyst Pharmaceuticals, Inc. (CPRX) Investor Outlook: Biotech Stock with a 70% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a prominent player in the biotechnology industry, continues to capture the attention of individual investors with its promising growth prospects and robust performance metrics. As..

Belite Bio, Inc (BLTE) Stock Analysis: Eyeing a 38.87% Upside with Breakthrough Biotech Innovations

Belite Bio, Inc (NASDAQ: BLTE) stands out in the biotechnology sector, capturing the attention of investors with a promising portfolio focused on addressing unmet medical needs in retinal degenerative diseases...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds